Publications by authors named "Josue Mora-Perez"
Background: Breast cancer subtype classification according to hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2) using immunohistochemistry is the standard practice for therapeutic decision making.
Objective: To design future studies information on characteristics and survival of each subtype is essential.
Method: We conducted a retrospective study to analyze clinical and pathologic features as well as survival data according to breast cancer immunohistochemistry subtype.
Background: The use of osteoclast inhibitors in metastatic bone disease, increase bone mineral density and reduce the risk of fracture, patients with osteonecrosis have been reported after the chronic use of these inhibitors. In our country, the use of osteoclast inhibitors is in the context of osteoporosis and bone metastases, so it is important to describe the incidence of this complication in Mexican population.
Objective: To describe the incidence of osteonecrosis of the jaws at the Centro Médico Nacional 20 de Noviembre, during the period from January 1st, 2010 to June 1st, 2016.
Article Synopsis
- Breast cancer subtype classification based on hormone receptors (HR) and HER2 is crucial for treatment decisions through immunohistochemistry.
- A retrospective study revealed different survival rates among breast cancer subtypes, showing HR(+)/HER2(-) patients had better overall survival compared to the triple negative subtype.
- Findings suggest that HR positive subtypes are more common and associated with longer survival rates compared to triple negative breast cancer.